TY - GEN
T1 - Combined systemic thrombolysis with alteplase and early hyperbaric oxygen therapy in experimental embolic stroke in rats
T2 - Relationship to functional outcome and reduction of structural damage
AU - Küppers-Tiedt, Lea
AU - Manaenko, Anatol
AU - Michalski, Dominik
AU - Guenther, Albrecht
AU - Hobohm, Carsten
AU - Wagner, Armin
AU - Zhang, John H.
AU - Schneider, Dietmar
N1 - Funding Information:
Acknowledgments This study was supported by a junior research grant of the Medical Faculty of the University of Leipzig. Conflict of interest statement
PY - 2011
Y1 - 2011
N2 - Introduction: The only causal therapy in ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (rtPA), but it is feasible only for few patients, and new therapies are needed. This study investigates the effects of systemic thrombolysis with rtPA combined with hyperbaric oxygen therapy (HBOT) in embolic stroke in rats. Methods: In 22 male Wistar rats, an embolic ischemic stroke was induced. The animals were randomized to one of four groups: control, thrombolysis alone, HBOT sequential or HBOT parallel with thrombolysis. HBOT (2.4 ATA, 1 h) started 45 min (sequential) or 120 min (parallel) after stroke. rtPA was given intravenously 120 min after stroke onset. Functional tests were performed after stroke induction and after treatment. After 6 h infarct volume and intracerebral hemorrhagic complications were assessed. Results: Compared to the control group only the combination of HBOT and thrombolysis significantly improved the functional outcome (p = 0.03) and reduced the infarct volume (p = 0.01), whereas thrombolysis alone did not show a significant benefit. In all treatment groups there was a trend towards fewer hemorrhagic transformations. Conclusion: Hyperbaric oxygen in combination with thrombolysis shows neuroprotection in acute ischemic stroke in rats by reducing infarct volume and improving functional outcome in the early poststroke period.
AB - Introduction: The only causal therapy in ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (rtPA), but it is feasible only for few patients, and new therapies are needed. This study investigates the effects of systemic thrombolysis with rtPA combined with hyperbaric oxygen therapy (HBOT) in embolic stroke in rats. Methods: In 22 male Wistar rats, an embolic ischemic stroke was induced. The animals were randomized to one of four groups: control, thrombolysis alone, HBOT sequential or HBOT parallel with thrombolysis. HBOT (2.4 ATA, 1 h) started 45 min (sequential) or 120 min (parallel) after stroke. rtPA was given intravenously 120 min after stroke onset. Functional tests were performed after stroke induction and after treatment. After 6 h infarct volume and intracerebral hemorrhagic complications were assessed. Results: Compared to the control group only the combination of HBOT and thrombolysis significantly improved the functional outcome (p = 0.03) and reduced the infarct volume (p = 0.01), whereas thrombolysis alone did not show a significant benefit. In all treatment groups there was a trend towards fewer hemorrhagic transformations. Conclusion: Hyperbaric oxygen in combination with thrombolysis shows neuroprotection in acute ischemic stroke in rats by reducing infarct volume and improving functional outcome in the early poststroke period.
KW - Embolic stroke
KW - Hyperbaric oxygen therapy
KW - Rat
KW - Thrombolysis
UR - http://www.scopus.com/inward/record.url?scp=79960694273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960694273&partnerID=8YFLogxK
U2 - 10.1007/978-3-7091-0693-8_28
DO - 10.1007/978-3-7091-0693-8_28
M3 - Conference contribution
C2 - 21725750
SN - 9783709106921
T3 - Acta Neurochirurgica, Supplementum
SP - 167
EP - 172
BT - Intracerebral Hemorrhage Research
PB - Springer-Verlag Wien
ER -